Search results
Results from the WOW.Com Content Network
In 2021, Demasi co-authored a paper with Robert DuBroff challenging statin therapy. [16] As of 2022, Demasi is a writer for the Brownstone Institute, an organization that has been criticized by medical experts for spreading misinformation against vaccines. [17] [18]
The Pioppi Diet: A 21-Day Lifestyle Plan (with Donal O'Neill), Penguin Books, 2017 ISBN 9781405932639; The 21-Day Immunity Plan, Yellow Kite, 2020 ISBN 9781529349672; A Statin-Free Life: A revolutionary life plan for tackling heart disease - without the use of statins, Hodder & Stoughton, 2021 ISBN 9781529354102
New research finds that many people currently taking statins to lower cholesterol may not actually need this medication. An analysis, published in JAMA Internal Medicine , investigates how statin ...
In other words, as many as 4 million people in the U.S. who currently take statins for primary prevention — meaning they have not had a cardiovascular event such as a stroke or heart attack ...
New research from the University of Hong Kong found that statins effectively lowered the risk of cardiovascular and all-cause mortality among adults 60 years of age and older — including people ...
Sinatra was the author of the monthly newsletter Heart, Health & Nutrition (ISSN 1554-2467), and has written or contributed to the following books: The Great Cholesterol Myth (Fair Winds Press, 2012) Earthing - the most important health discovery ever? (Basic Health, 2010) Bottom Line's The Healing Kitchen (Bottom Line, 2010)
Part of the power of statins lies in the fact that they cause few side effects. “Generally, about 90 out of 100 people have no trouble with a stain,” says Dr. Blumenthal.
Type 2 statins Statins that are fully synthetic and have larger groups linked to the HMG-like moiety are often referred to as type 2 statins. One of the main differences between the type 1 and type 2 statins is the replacement of the butyryl group of type 1 statins by the fluorophenyl group of type 2 statins.